Cardiovascular mortality after radiotherapy for breast cancer. Study showed only estimates of use of adjuvant radiotherapy

Comment

Ian H Kunkler. BMJ. 2003.

. 2003 May 3;326(7396):983.

doi: 10.1136/bmj.326.7396.983.

No abstract available

Comment on

Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women.
Darby S, McGale P, Peto R, Granath F, Hall P, Ekbom A. Darby S, et al. BMJ. 2003 Feb 1;326(7383):256-7. doi: 10.1136/bmj.326.7383.256. BMJ. 2003. PMID: 12560277 Free PMC article. No abstract available.

1. Darby S, McGale P, Peto R, Granath F, Hall P, Akbom A. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women. BMJ. 2003;326:256–257. . (1 February.) - PMC - PubMed
1. Hojris I, Overgaard M, Christensen JJ, Overgaard J. Morbidity and mortality of ischaemic heart disease in 3083 high-risk breast cancer patients given adjuvant systemic therapy treatment with or without postmastectomy irradiation: analysis of DBCG 82b and 82c randomised trials. Lancet. 1999;354:1425–1430. - PubMed
1. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet. 2000;355:1757–1750. - PubMed
1. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997;337:949–955. - PubMed
1. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962. - PubMed